Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuronal death enhanced by N-methyl-D-aspartate antagonists.

C Ikonomidou1, V Stefovska, L Turski

  • 1Department of Pediatric Neurology, Children's Hospital, Charité-Virchow Clinics, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany. hrissanthi.ikonomidou@charite.de

Proceedings of the National Academy of Sciences of the United States of America
|November 1, 2000
PubMed
Summary

Glutamate antagonists targeting N-methyl-d-aspartate receptors may worsen neurodegeneration in mature brains. However, blocking glutamate at alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors shows neuroprotective potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum.

Amino acids·2013
Same author

Antiepileptic drugs and the developing brain.

Cellular and molecular life sciences : CMLS·2006
Same author

Acute and long-term proteome changes induced by oxidative stress in the developing brain.

Cell death and differentiation·2005
Same author

Modeling pediatric head trauma: mechanisms of degeneration and potential strategies for neuroprotection.

Restorative neurology and neuroscience·2003
Same author

Glutamate signaling and the fetal alcohol syndrome.

Mental retardation and developmental disabilities research reviews·2002
Same author

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Journal of neurochemistry·2001

Area of Science:

  • Neuroscience
  • Neurobiology
  • Pharmacology

Background:

  • Glutamate plays a dual role in neuronal health, supporting development but causing damage in mature brains post-injury.
  • Glutamate antagonists are explored for neuroprotection in acute brain injury and chronic neurodegenerative diseases like Huntington's disease.

Purpose of the Study:

  • To investigate the differential effects of N-methyl-d-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor antagonists on neurodegeneration.

Main Methods:

  • Induction of progressive neurodegeneration in the basal ganglia using 3-nitropropionate or in the hippocampus via traumatic brain injury.
  • Administration of NMDA and AMPA receptor antagonists to assess their impact on neurodegeneration.

Main Results:

Related Experiment Videos

  • NMDA receptor antagonists exacerbated neurodegeneration in both models.
  • AMPA receptor antagonists demonstrated neuroprotective effects, ameliorating neuronal loss.

Conclusions:

  • NMDA receptor antagonists may increase neurodestruction in mature brains with slowly progressing neurodegeneration.
  • Blocking glutamate at AMPA receptors could offer a neuroprotective strategy for conditions involving chronic neurodegeneration.